Columbia Business School Names New Indian Executive-in-Residence
Columbia Business School this week announced that Surya N. Mohapatra, former chairman and chief executive officer of Quest Diagnostics Incorporated, will be its next executive-in-residence. Mohapatra, one of a select group of India-born Fortune 500 chief executive officers, brings more than 30 years of broad experience in the health care industry, including cardiovascular research, diagnostic imaging and diagnostic testing. He advocates on behalf of patients, calling for increased patient empowerment and accountability to improve healthcare and reduce costs.
Mohaptra’s areas of interest include patient centricity, growth strategy, global health, information technology and innovation. He joined Quest Diagnostics in 1999, and before that he served as senior vice president and a member of the executive committee of Picker International, now part of Phillips Medical Systems.
Mohapatra is also a member of the board of directors of Xylem Corporation, a trustee of Rockefeller University and a member of the Corporate Advisory Board of Johns Hopkins Carey Business School. “Dr. Mohapatra and his considerable experience in healthcare will help facilitate and strengthen collaboration among Columbia Business School and other schools in medical science, engineering and public health,” said Dean Glenn Hubbard. “We are excited to welcome him as our newest Executive in Residence.”
Learn more about Mohapatra’s appointment at Columbia Business School.